Mediplantex National Pharmaceutical JSC (HNX:MED)

Vietnam flag Vietnam · Delayed Price · Currency is VND
22,800
0.00 (0.00%)
At close: Aug 20, 2025
Market Cap282.95B
Revenue (ttm)360.49B
Net Income (ttm)11.67B
Shares Out12.41M
EPS (ttm)940.68
PE Ratio24.24
Forward PEn/a
Dividend900.00 (3.95%)
Ex-Dividend DateJul 16, 2025
Volume473,300
Average Volume24,406
Open22,800
Previous Closen/a
Day's Range22,800 - 22,800
52-Week Range22,800 - 28,600
Beta0.10
RSI42.33
Earnings DateJul 29, 2025

About HNX:MED

Mediplantex National Pharmaceutical Joint Stock Company produces and trades in pharmaceutical products in Vietnam and internationally. The company offers pharmaceutical products in various categories, including drugs from herbals; analgesics, corticosteroid, and anti-inflammatory drugs; antibiotics; cerebral circulation, heart, and lung drugs; anti-malarial, demostasis, gout, diabetes, allergies, and osteoarthritis drugs; acid amin, vitamins, and minerals; and other products. It also provides pharmaceutical chemicals and medicinal herbs; and ex... [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 328
Stock Exchange Hanoi Stock Exchange
Ticker Symbol MED
Full Company Profile

Financial Performance

In 2024, HNX:MED's revenue was 443.14 billion, an increase of 10.03% compared to the previous year's 402.74 billion. Earnings were 15.25 billion, an increase of 29.83%.

Financial Statements

News

There is no news available yet.